Those who act often succeed; those who journey often arrive | Dalton Venture 2023 Year in Review

"

To Our Dalton Partners:

The first light of 2024 has quietly arrived, ushered in by time's steady hand.

Looking back at 2023, "persistence" and "reinvention" were undeniably the dominant themes of the capital markets. Amid this evolving venture capital symphony, Dalton Venture remained on the stage of healthcare innovation — discerning industry growth opportunities, empowering innovative companies to grow with resilience, and redefining investment value for a new cycle.

Dalton's investment wisdom lies at both ends of a balance scale: an unchanging core on one side, continuous breakthroughs on the other. Facing market shifts, we have nimbly established new equilibrium through precise foresight of trends and timing, exploring and positioning around investment strategy and fund structure to secure early-mover advantage.

Despite market uncertainty, we firmly believe that "healthcare's long-term upward trajectory" is the one constant certainty. Only by staying attuned to the pulse of the era and cultivating our focus can we overcome all obstacles. The road ahead is long, but we have dreams as companions; the struggle is arduous, but we have conviction as our strength.

This is how we journeyed through 2023. In 2024, we look forward to walking further together, side by side.

Dalton Venture, ever moving forward

Tap the images below to revisit our 2023